Sponsor Pipeline

SetPoint Medical Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04539964 Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis Rheumatoid Arthritis Active, Not Recruiting
Not specified
NCT06796504 The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple… Relapsing Remitting Multiple Sclerosis Recruiting
NCT04862117 Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With… Rheumatoid Arthritis Active, Not Recruiting
NCT07489326 The SetPoint System Safety & Performance Post-Approval Study Rheumatoid Arthritis Not Yet Recruiting
Disease Areas
Rheumatoid Arthritis (3) Multiple Sclerosis (1)
Get alerts when SetPoint Medical Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free